ERBB2 and ovarian carcinoma: In a previous study, we found that baicalein inhibited ErbB2-mediated malignant transformation of ErbB2-overexpressing ovarian cancer cells by downregulating ErbB2 gene expression at the transcriptional level (unpublished results).